MA
Md Azharuddin Peada
About Md Azharuddin Peada
Data last updated:
Md Azharuddin Peada is a Director at Jebandeep Healthcare Private Limited (since 2026) and Designated Partner at Biospell Pharmaceutical Llp (since 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Jebandeep Healthcare Private Limited U86909WR2026PTC294857 | Director | 26 Jun 2026 | 2026 | Active | |
| Biospell Pharmaceutical Llp ACE-9899 | Designated Partner | 18 Jan 2024 | 2024 | Active |
Board colleagues of Md Azharuddin Peada
| Name | DIN | Company | Designation |
|---|---|---|---|
| Azad Hossain Sardar | 11791522 | Jebandeep Healthcare Private Limited | Director |
| Ikramulla Peada | 10470355 | Biospell Pharmaceutical Llp | Designated Partner |
| Ridwan Islam | 10470353 | Biospell Pharmaceutical Llp | Designated Partner |
| Roji Taslima | 10470354 | Biospell Pharmaceutical Llp | Designated Partner |
| Soriful Shah | 10470357 | Biospell Pharmaceutical Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Md Azharuddin Peada
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Md Azharuddin Peada
Md Azharuddin Peada currently holds 2 directorships: Jebandeep Healthcare Private Limited (Director, since 26 Jun 2026); Biospell Pharmaceutical Llp (Designated Partner, since 18 Jan 2024).
Md Azharuddin Peada was first appointed on 18 Jan 2024 as Designated Partner at Biospell Pharmaceutical Llp. The most recent appointment on record is 26 Jun 2026 at Jebandeep Healthcare Private Limited.
The current boards of Md Azharuddin Peada's companies include Azad Hossain Sardar (Jebandeep Healthcare Private Limited), Ikramulla Peada (Biospell Pharmaceutical Llp), Ridwan Islam (Biospell Pharmaceutical Llp), Roji Taslima (Biospell Pharmaceutical Llp), Soriful Shah (Biospell Pharmaceutical Llp).